5,7-胆甾二烯-3β- 醇

产品名称：

434-16-2
Cholecalciferol Impurity B
(-)-7-Dehydrocholesterol
Provitamin D₃
3β-Hydroxy-5,7-cholestadiene
5,7-Cholestadien-3β-ol
7-Dehydrocholesterol
7-脱氢胆固醇
前维生素 D ₃
5,7-胆甾二烯-3β- 醇
(-)-7-脱氢胆固醇
3＆＃946;-羟基-5,7-胆甾

产品介绍：

产品说明

一般描述

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

生化/生理作用

下调培养的 Smith-Lemi-Opitz 综合征皮肤成纤维细胞的胆固醇生物合成。

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAC5946 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式	C₂₇H₄₄O
分子量	384.64
Beilstein	2224615
MDL编号	MFCD00003624

产品性质

等级	certified reference material pharmaceutical secondary standard
形式	powder
包装	pkg of 100 mg
mp	148-152 ℃ (lit.)
储存温度	-10 to -25℃
SMILES string	[H][C@@]1(CC[C@@]2([H])C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCCC(C)C
InChI	1S/C27H44O/c1-18(2)7-6-8-19(3)23-11-12-24-22-10-9-20-17-21(28)13-15-26(20,4)25(22)14-16-27(23,24)5/h9-10,18-19,21,23-25,28H,6-8,11-17H2,1-5H3/t19-,21+,23-,24+,25+,26+,27-/m1/s1
InChI key	UCTLRSWJYQTBFZ-DDPQNLDTSA-N

安全信息

储存分类代码	13 - Non Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable